NOTICE OF LIMITED COMPETITION - POST-DIABETES PREVENTION PROGRAM (DPP) 
FOLLOW-UP STUDIES

Release Date:  April 23, 2001

NOTICE:  NOT-DK-01-013

National Institute of Diabetes and Digestive and Kidney Diseases
 (http://www.niddk.nih.gov/)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
is announcing a limited competition for competing applications from NIDDK-
designated Diabetes Prevention Program (DPP) Clinical Centers and the DPP 
Coordinating Center. The DPP is a multicenter controlled clinical trial 
examining the efficacy of an intensive life-style intervention or metformin 
to prevent or delay the onset of diabetes in a population at risk due to the 
presence of impaired glucose tolerance (IGT).  This post-DPP follow-up study 
is intended to enable DPP investigators to continue a long-term follow-up of 
the DPP cohort. The DPP cohort, including 45% minorities, is the largest 
population of individuals with impaired glucose tolerance (IGT) ever to be 
studied.  The DPP Clinical Centers and the DPP Coordinating Center possess 
the infrastructure, organization, leadership, staffing and randomized cohort 
of volunteers to address clinically important research questions that will 
remain following study end.

NIDDK staff will contact the current grantees directly regarding application 
procedures and format.

INQUIRIES

Inquiries are encouraged, and the opportunity to clarify issues and answer 
questions is welcome.  Inquiries may be directed to:

Sanford A. Garfield, Ph.D.
Senior Advisor for Biometry and Behavioral Research
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Health
6700 Democracy Blvd. Room 685
Rockville, MD  20814-9692
Phone:  301-594-8803
Fax:  301-402-62711
e-mail:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®